MDNC (Medinotec) Shares Outstanding (EOP): 11.76 Mil (As of Feb. 2026)


MDNC Medinotec Inc MDNC
24 GF Score
Price $5.00
! 2 Warning Signs
View Full Analysis

What is Medinotec Shares Outstanding (EOP)?

Medinotec MDNC 24 Shares Outstanding (EOP) is 11.76 Mil as of Feb. 2026. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Medinotec's shares outstanding for the quarter that ended in Feb. 2026 was 11.76 Mil.

Medinotec's quarterly shares outstanding stayed the same from Nov. 2025 (11.76 Mil) to Feb. 2026 (11.76 Mil).

Medinotec's annual shares outstanding increased from Feb. 2025 (11.73 Mil) to Feb. 2026 (11.76 Mil). It means Medinotec issued new shares from Feb. 2025 to Feb. 2026 .


Medinotec  (OTCPK:MDNC) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Medinotec Shares Outstanding (EOP) Related Terms


Medinotec Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Medinotec's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinotec Shares Outstanding (EOP) Chart

Medinotec Annual Data
Trend Feb22 Feb23 Feb24 Feb25 Feb26
Shares Outstanding (EOP)
11.73 11.73 11.73 11.73 11.76

Medinotec Quarterly Data
Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.73 11.73 11.76 11.76 11.76

MDNC vs NVNO, APYX, RDGL: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Medinotec's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinotec Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Medinotec's Shares Outstanding (EOP) falls into.


MDNC
24GF Score
Medinotec Inc MDNC
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinotec Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 11.76 Mil mean?
Medinotec (MDNC) has a Shares Outstanding (EOP) of 11.76 Mil as of Feb. 2026. The total shares a company has outstanding, at period-end. View historical data on Medinotec and its competitors.
Is Medinotec's Shares Outstanding (EOP) too high?
Medinotec's current Shares Outstanding (EOP) is 11.76 Mil. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Shares Outstanding (EOP) compare to NVNO and APYX?
Medinotec's Shares Outstanding (EOP) of 11.76 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Medinotec and its competitors. Medinotec's current Shares Outstanding (EOP) is 11.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Shares Outstanding (EOP) of 11.76 Mil. The current Shares Outstanding (EOP) is 11.76 Mil. Medinotec's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Medinotec (MDNC), the current Shares Outstanding (EOP) is 11.76 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medinotec Business Description

Address Stand 299 Avant Garde Avenue, 10 New Market Street, Northlands Deco Park, North Riding, Johannesburg, GT, ZAF, 2169
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score

Get the complete analysis for MDNC

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.00
Price